N/A
Average AnalystN/A
Top AnalystBearish
Stock Target AdvisorN/A
Average UserEUR 7.32
-0.17 (-2.27%)
EUR 1.08B
300.00
EUR 0.00
Based on the Adaptive Biotechnologies Corporation stock forecast from 0 analysts, the average analyst target price for Adaptive Biotechnologies Corporation is not available over the next 12 months. Adaptive Biotechnologies Corporation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Adaptive Biotechnologies Corporation is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Adaptive Biotechnologies Corporation’s stock price was EUR 7.32. Adaptive Biotechnologies Corporation’s stock price has changed by +1.95% over the past week, +14.44% over the past month and +118.43% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The stock is trading high compared to its peers median on a price to book value basis.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.
This stock has shown below median earnings growth in the previous 5 years compared to its sector